Stephen Heitner, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Researchers
Stephen Heitner, MD

Stephen Heitner, MD

Researcher
Vice President Clinical Research
Cytokinetics, Inc.
280 East Grand Avenue
South San Francisco, California, United States
Stephen Heitner is a Senior Medical Director at Cytokinetics. Previously he worked as a Cardiologist at Oregon Health & Science University (OHSU). He received his medical degree from University of the Witwatersrand, Johannesburg South Africa followed by residency in Internal medicine from Albert Einstein Medical Center, Philadelphia and fellowship in cardiology from Cooper University Hospital, Camden, New Jersey. He has a special interest in amyloidosis, cardiac amyloidosis,  cardio-oncology and hypertrophic cardiomyopathy. Dr. Heitner specializes in caring for patients with uncommon and complex cardiac conditions.  
 
Dr. Heitner is also an expert in cardiac imaging, and has implemented the latest developments in cardiac ultrasound technology in to the echocardiography laboratory at OHSU. Through the use of contrast echocardiography, 3D echocardiography, and even newer promising technologies, Dr. Heitner is helping improve the detection of disease, as well as guide non-surgical repair of structural cardiac problems (e.g. transcutaneous valve replacements, septal defect repairs).
 
 
Representative Publications:
 
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close